Evidence map›Paper›PMID 21483806›Full record

ArticlePLoS genetics2011

Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish.

Adriana Rodríguez-Marí, Catherine Wilson, Tom A Titus, Cristian Cañestro, Ruth A BreMiller, Yi-Lin Yan, Indrajit Nanda, Adam Johnston, John P Kanki, Erin M Gray and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Regulation of early gonocyte differentiation in zebrafish.Biochemical Society transactions · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Direct male development in chromosomally ZZ zebrafish.Frontiers in cell and developmental biology · 2024
    Article
  15. Review
  16. Learning from Zebrafish Hematopoiesis.Advances in experimental medicine and biology · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Adriana Rodríguez-MaríInstitute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
Catherine Wilson
Tom A Titus
Cristian Cañestro
Ruth A BreMiller
Yi-Lin Yan
Indrajit Nanda
Adam Johnston
John P Kanki
Erin M Gray
Xinjun He
Jan Spitsbergen
Detlev Schindler
John H Postlethwait
University of Oregon · USDana-Farber Cancer Institute · USUniversity of Würzburg · DEOregon State University · US

Funding

Xenograft CoreP01HL048546 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GROMPE, MARKUS · 1994 to 2020
$36.4M
RESOURCES FOR TELEOST GENE DUPLICATES AND HUMAN DISEASER01RR020833 · NCRR · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2005 to 2011
$3.6M
Mechanisms of Sex Determination in ZebrafishR01GM085318 · NIGMS · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2010 to 2018
$2.1M
NCRR NIH HHS 2R01RR020833NCRR NIH HHS R01 RR020833NHLBI NIH HHS 1P01HL048546NHLBI NIH HHS P01 HL048546NIGMS NIH HHS 1R01GM085318NIGMS NIH HHS R01 GM085318
6 · The paper itself

Abstract

Mild mutations in BRCA2 (FANCD1) cause Fanconi anemia (FA) when homozygous, while severe mutations cause common cancers including breast, ovarian, and prostate cancers when heterozygous. Here we report a zebrafish brca2 insertional mutant that shares phenotypes with human patients and identifies a novel brca2 function in oogenesis. Experiments showed that mutant embryos and mutant cells in culture experienced genome instability, as do cells in FA patients. In wild-type zebrafish, meiotic cells expressed brca2; and, unexpectedly, transcripts in oocytes localized asymmetrically to the animal pole. In juvenile brca2 mutants, oocytes failed to progress through meiosis, leading to female-to-male sex reversal. Adult mutants became sterile males due to the meiotic arrest of spermatocytes, which then died by apoptosis, followed by neoplastic proliferation of gonad somatic cells that was similar to neoplasia observed in ageing dead end (dnd)-knockdown males, which lack germ cells. The construction of animals doubly mutant for brca2 and the apoptotic gene tp53 (p53) rescued brca2-dependent sex reversal. Double mutants developed oocytes and became sterile females that produced only aberrant embryos and showed elevated risk for invasive ovarian tumors. Oocytes in double-mutant females showed normal localization of brca2 and pou5f1 transcripts to the animal pole and vasa transcripts to the vegetal pole, but had a polarized rather than symmetrical nucleus with the distribution of nucleoli and chromosomes to opposite nuclear poles; this result revealed a novel role for Brca2 in establishing or maintaining oocyte nuclear architecture. Mutating tp53 did not rescue the infertility phenotype in brca2 mutant males, suggesting that brca2 plays an essential role in zebrafish spermatogenesis. Overall, this work verified zebrafish as a model for the role of Brca2 in human disease and uncovered a novel function of Brca2 in vertebrate oocyte nuclear architecture.

Indexed as

Genomic InstabilityOogenesisSpermatogenesisAmino Acid SequenceAnimalsApoptosisBRCA2 ProteinCell Transformation, NeoplasticDisease Models, AnimalFanconi AnemiaFemaleGenes, p53HumansMaleMolecular Sequence DataMutagenesis, InsertionalBRCA2 Proteinbrca2 protein, zebrafishZebrafish Proteins

Identifiers

PMID21483806
PMCPMC3069109
OpenAlexW2120636655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.